Xinlan Lu

1.1k citations
42 papers · 872 · h-index 18

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
  • Hepatology top 10%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Circular RNAs in diseases 6
    • Ubiquitin and proteasome pathways 4
    • RNA modifications and cancer 3
    • DNA Repair Mechanisms 2
    • MicroRNA in disease regulation 6
    • Cancer-related molecular mechanisms research 6

Xinlan Lu

40 papers receiving 863 citations

Peers

Xinlan Lu
Comparison fields: 5 of 81
  • Cancer Research 329
  • Hepatology 69
  • Toxicology 23
  • Molecular Biology 430
  • Gastroenterology 31
Replace Jen‐Tsun Lin with:
Jen‐Tsun Lin Taiwan
Xinzheng Dai China
Xuelong Jiao China
Xuequan Yao China
Haihua Qian China
Wuxuan Mei China
Qingqu Guo China
Maitane Asensio Spain
Gregory H. Ripple United States
Xinlan Lu relative to Jen‐Tsun Lin Taiwan Jen‐Tsun Lin's profile →
Citations per field
00.5×5.5×
Jen‐Tsun Lin · 1×
Citations per year

Countries citing papers authored by Xinlan Lu

Since Specialization
Citations

This map shows the geographic impact of Xinlan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinlan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinlan Lu more than expected).

Fields of papers citing papers by Xinlan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinlan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinlan Lu. The network helps show where Xinlan Lu may publish in the future.

Co-authors

The 25 scholars most cited alongside Xinlan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xinlan Lu Line = papers co-authored together Xinlan Lu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2018111
2 201969
3 201253
4 201650
5 201947
6 201644
7 202042
8 201741
9 201433
10 201533
11 201830
12 202029
13 201827
14 202026
15 201825
16 201822
17 201319
18 202217
19 201417
20 202015

About Xinlan Lu

Xinlan Lu is a scholar working on Molecular Biology, Cancer Research, Pharmacology, Oncology and Biomedical Engineering, having authored 42 papers that have together received 872 indexed citations. Recurring topics across this work include Circular RNAs in diseases (6 papers), MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers), Ubiquitin and proteasome pathways (4 papers), RNA modifications and cancer (3 papers), Innovative Microfluidic and Catalytic Techniques Innovation (3 papers), DNA Repair Mechanisms (2 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Cancer Research (329 citations), Hepatology (69 citations), Toxicology (23 citations), Molecular Biology (430 citations) and Gastroenterology (31 citations). Xinlan Lu has collaborated with scholars based in China, Australia and Hong Kong. Frequent co-authors include Mudan Ren, Shuixiang He, Yarui Li, Guifang Lu, Yan Zhao, Guifang Lu, Dan Guo, Xin Wang, Dan Zhang and Yanan Hu. Their work appears in journals such as Oncology Reports, Digestive Diseases and Sciences, Scandinavian Journal of Gastroenterology, Journal of Gastroenterology and Hepatology and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact